Trial Profile
Evaluation of the Efficacy and Safety of Fenofibrate and Ezetimibe Coadministration in Patients With Mixed Hyperlipidemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Fenofibrate
- Indications Hyperlipidaemia; Hyperlipoproteinaemia type V; Lipid metabolism disorders
- Focus Pharmacodynamics; Registrational; Therapeutic Use
- Sponsors Merck Sharp & Dohme; Organon
- 30 Aug 2005 New trial record.